Literature DB >> 3039349

Rapid and selective alterations in the expression of cellular genes accompany conditional transcription of Ha-v-ras in NIH 3T3 cells.

R D Owen, M C Ostrowski.   

Abstract

Hormone treatment of NIH 3T3 cells that contain recombinant fusions between the mouse mammary virus long terminal repeat and the v-ras gene of Harvey murine sarcoma virus results in conditional expression of the ras p21 gene product. Levels of ras mRNA and p21 are maximal after 2 to 4 h of hormone treatment. Analysis of cellular RNA by Northern blotting and nuclease S1 protection assays indicates that the expression of two cellular RNA species increases with kinetics similar to v-ras: v-sis-related RNA and retrovirus-related VL30 RNA. Run-on transcription in isolated nuclei shows that the increase in v-sis-related RNA is not dependent on transcription and therefore must arise by a post-transcriptional mechanism. The increase in VL30 expression is a transcriptional effect. Hormone treatment of normal NIH 3T3 cells has no effect on the expression of these DNA sequences. These results suggest that v-ras stimulation of autocrine factors may play a role in transformation of cells by this gene and also suggest a reverse genetic strategy to determine the nucleic acid sequences and cellular factors involved in the regulation of gene expression that is observed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3039349      PMCID: PMC365385          DOI: 10.1128/mcb.7.7.2512-2520.1987

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5' element and c-fos 3' sequences.

Authors:  R Treisman
Journal:  Cell       Date:  1985-10       Impact factor: 41.582

2.  Heterogeneity of "virus-like" genes encoding retrovirus-associated 30S RNA and their organization within the mouse genome.

Authors:  E Keshet; Y Shaul; J Kaminchik; H Aviv
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

3.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

4.  During B-cell differentiation enhancer activity and transcription rate of immunoglobulin heavy chain genes are high before mRNA accumulation.

Authors:  T Gerster; D Picard; W Schaffner
Journal:  Cell       Date:  1986-04-11       Impact factor: 41.582

Review 5.  Viral oncogenes.

Authors:  J M Bishop
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

6.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

7.  Transcriptional regulation of hemoglobin switching in chicken embryos.

Authors:  M Groudine; M Peretz; H Weintraub
Journal:  Mol Cell Biol       Date:  1981-03       Impact factor: 4.272

8.  Isolation of cellular genes differentially expressed in mouse NIH 3T3 cells and a simian virus 40-transformed derivative: growth-specific expression of VL30 genes.

Authors:  K Singh; S Saragosti; M Botchan
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

9.  Defective retrovirus-like 30S RNA species of rat and mouse cells are infectious if packaged by type C helper virus.

Authors:  E M Scolnick; W C Vass; R S Howk; P H Duesberg
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

10.  Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells.

Authors:  M E Greenberg; L A Greene; E B Ziff
Journal:  J Biol Chem       Date:  1985-11-15       Impact factor: 5.157

View more
  14 in total

Review 1.  Control of myogenic differentiation by cellular oncogenes.

Authors:  M D Schneider; E N Olson
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

2.  Regulation of expression of the c-sis proto-oncogene.

Authors:  L Ratner
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

3.  Transcriptional activation of a conserved sequence element by ras requires a nuclear factor distinct from c-fos or c-jun.

Authors:  R D Owen; M C Ostrowski
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

4.  Negative regulation of transcription in vitro by a glucocorticoid response element is mediated by a trans-acting factor.

Authors:  S J Langer; M C Ostrowski
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

5.  ras oncogene activation of a VL30 transcriptional element is linked to transformation.

Authors:  R D Owen; D M Bortner; M C Ostrowski
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

6.  Independent regulation of mouse VL30 retrotransposon expression in response to serum and oncogenic cell transformation.

Authors:  L Eaton; J D Norton
Journal:  Nucleic Acids Res       Date:  1990-04-25       Impact factor: 16.971

7.  Desensitization of prostaglandin F2 alpha-stimulated inositol phosphate generation in NIH-3T3 fibroblasts transformed by overexpression of normal c-Ha-ras-1, c-Ki-ras-2 and c-N-ras genes.

Authors:  F M Black; M J Wakelam
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

8.  Alpha B crystallin accumulation is a specific response to Ha-ras and v-mos oncogene expression in mouse NIH 3T3 fibroblasts.

Authors:  R Klemenz; E Fröhli; A Aoyama; S Hoffmann; R J Simpson; R L Moritz; R Schäfer
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

9.  Anoxia-inducible rat VL30 elements and their relationship to ras-containing sarcoma viruses.

Authors:  B A Firulli; G R Anderson; D L Stoler; S D Estes
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

10.  A ras-dependent pathway abolishes activity of a muscle-specific enhancer upstream from the muscle creatine kinase gene.

Authors:  E A Sternberg; G Spizz; M E Perry; E N Olson
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.